Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172) (vol 52, pg 394, 2011)
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate
A phase I study of topotecan and gemcitabine in advanced solid tumors
A phase field model for isothermal crystallization of oxide melts
A photonic readout and data acquisition system for deep-sea neutrino telescopes
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer
A phytoceramide analog stimulates the production of chemokines through CREB activation in human endothelial cells
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer
A phylogenetic revision of the Glaucopsyche section (Lepidoptera: Lycaenidae), with special focus on the Phengaris-Maculinea clade
A phylogenetically controlled analysis of the roles of reproductive traits in plant invasions
A phase field model with non-local and anisotropic potential
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
A phase diagram for a stochastic reaction diffusion system
A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human alpha(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer
A phosphatase threshold sets the level of Cdk1 activity in early mitosis in budding yeast
A pharmacy's journey toward the patient-centered medical home
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer
A phenology-based approach to map crop types in the San Joaquin Valley, California
A physiological systems approach to modeling and resetting of mouse thermoregulation under heat stress
A pharmacoepidemiological analysis of clozapine use in a region of Australia Reply
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
A physical mechanism to explain the delivery of chemical penetration enhancers into skin during transdermal sonophoresis - Insight into the observed synergism
A phenomenological approach to modeling chemical dynamics in nonlinear and two-dimensional spectroscopy
A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy
A philosophy of science perspective on the quantitative analysis of behavior
A phase 2 study of oral MKC-1, an inhibitor of importin-beta, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer
A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
A physically-based correlation of irradiation-induced transition temperature shifts for RPV steels
A pharmacological investigation of the venom extract of the Australian box jellyfish, Chironex fleckeri, in cardiac and vascular tissues
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncology group study
A phantom for visualization of three-dimensional drug release by ultrasound-induced mild hyperthermia
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (vol 127, pg 538, 2012)
A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer
A phase I study evaluating ibritumomab tiuxetan (Zevalin (R)) in combination with bortezomib (Velcade (R)) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
A phenomenological model to describe turbulent friction in permeable-wall flows
A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer Final Results
A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform
A phase 2B study of MK-7009 (vaniprevir) in patients with genotype 1 HCV infection who have failed previous pegylated interferon and ribavirin treatment
A pharmacoeconomical analysis of idiopathic epilepsy
A phylogenetic re-evaluation of Arthrinium
A physiology-based parametric imaging method for FDG-PET data
A photobioreactor for microalgae cultivation with internal illumination considering flashing light effect and optimized light-source arrangement
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with <= 30% blasts
A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia
A physics-based fractional order model and state of energy estimation for lithium ion batteries. Part I: Model development and observability analysis
A physics-based fractional order model and state of energy estimation for lithium ion batteries. Part II: Parameter identification and state of energy estimation for LiFePO4 battery
A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
A phase 1 study of the Janus kinase 2 (JAK2)(V617F) inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
A photometric study of the peculiar and potentially double ringed, non-barred galaxy: PGC 1000714
A physics-based model for maintenance of the pH gradient in the gastric mucus layer
A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma
A photocapacitor based on organometal halide perovskite and PANI/CNT composites integrated using a CNT bridge
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy
A physiological and behavioral system for hearing restoration with cochlear implants
A phenomenological dislocation mobility law for bcc metals
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
A photoelectron spectroscopic and computational study of the o-dicarbadodecaborane parent anion
A phased strategy to differentiate human CD14(+) monocytes into classically and alternatively activated macrophages and dendritic cells
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
A photochemical flow reactor for large scale syntheses of aglain and rocaglate natural product analogues
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
A physically-based hybrid framework to estimate daily-mean surface fluxes over complex terrain
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer